Care plan for sickle cell pain crises in the ER
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial studies an approach to improve care during emergency room visits for uncomplicated sickle cell pain crises. It may help by guiding how pain is treated in the ER and tracking outcomes for people with sickle cell disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have sickle cell disease (not sickle cell trait).
- You are coming to the emergency department for an uncomplicated pain crisis.
- You received at least one opioid for pain in the emergency department.
- You do NOT have acute chest syndrome during this ER visit.
- You do NOT have a fever higher than 38.5°C (or 101.3°F) in the ER.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at the best time to start giving ketamine, a pain-relieving medicine, for sickle cell pain. It aims to find out whether giving it earlier or later in your visit works better and is safer.
This trial compares different ways to manage sickle cell pain crises in the hospital, using a flexible 'platform' design to test combinations of pain medicines. It aims to find the safest and most effective approach to reduce pain and improve recovery.
This study looks at how children with sickle cell disease experience pain crises (severe pain episodes that often require hospital care). Researchers want to understand what happens during these crises, which might help improve care and treatment.
This trial tests whether a numbing medicine (lidocaine) given through a vein can help reduce the amount of strong painkillers (morphine or oxycodone) needed for a sickle cell pain crisis or acute chest syndrome. It aims to ease pain and possibly lower side effects from opioids.
This study compares two pain medicines (parecoxib and morphine) given to people with sickle cell disease who come to the emergency room with a painful crisis. It aims to see which medicine works better and is safer for easing the pain.
This trial tests an intravenous medicine called L-citrulline for young people with sickle cell disease who are in the emergency department for a painful crisis (vaso-occlusive crisis). It aims to see if it can ease the pain and help you recover faster.
Hear when a new Sickle Cell Crisis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.